BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Marco V, Craxì A. Chronic hepatitis B: who to treat and which choice of treatment? Expert Rev Anti Infect Ther 2009;7:281-91. [PMID: 19344242 DOI: 10.1586/eri.09.4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Dusheiko GM, Jacobs MG. Perspectives on the management of chronic hepatitis B and C. Expert Review of Anti-infective Therapy 2014;7:243-7. [DOI: 10.1586/eri.09.16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Liu FJ, Chen EQ, Zhou QL, Zhou TY, Liu C, Liu L, Cheng X, Tang H. Functional Characterization of Interferon Regulation Element of Hepatitis B virus Genome In Vivo. Indian J Virol 2012;23:278-85. [PMID: 24293814 DOI: 10.1007/s13337-012-0091-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Aspinall EJ, Hawkins G, Fraser A, Hutchinson SJ, Goldberg D. Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med (Lond). 2011;61:531-540. [PMID: 22114089 DOI: 10.1093/occmed/kqr136] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]
4 Ji D, Liu Y, Si LL, Li L, Chen GF, Xin SJ, Zhao JM, Xu D. Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients. Clin Chim Acta. 2011;412:305-313. [PMID: 21056552 DOI: 10.1016/j.cca.2010.10.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
5 Gantier MP, Tong S, Behlke MA, Irving AT, Lappas M, Nilsson UW, Latz E, McMillan NA, Williams BR. Rational design of immunostimulatory siRNAs. Mol Ther 2010;18:785-95. [PMID: 20125126 DOI: 10.1038/mt.2010.4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
6 Rein DB, Lesesne SB, O'Fallon A, Weinbaum CM. Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008. Hepatology 2010;51:431-4. [PMID: 19902482 DOI: 10.1002/hep.23353] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
7 Amini-Bavil-Olyaee S, Vucur M, Luedde T, Trautwein C, Tacke F. Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains. J Virol. 2010;84:1026-1033. [PMID: 19889778 DOI: 10.1128/jvi.01796-09] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]